Cincinnati Children’s researchers collaborate with colleagues in Uganda and beyond to help children where the disease burden is highest. Learn more on our Science Blog:
@cincychildrens.bsky.social
A 10-year study in Uganda shows hydroxyurea dramatically reduces complications and death from sickle cell anemia, offering hope for wider global treatment access.
Ugandan children with sickle cell anemia who received 10 years of hydroxyurea therapy had sustained laboratory and clinical benefits, improved growth, and few toxic effects. Read the full summary of research findings: https://nej.md/4nRSBlT
